New Research on Charity Care and the 340B Program From the Health Equity Collaborative
The State of U.S. Charity Care: Solutions to Improve the Patient Experience and Achieve More Equitable Health OutcomesWASHINGTON, DC /...
Healthcare
From Struggles to Solutions: How Kennett Schools Transformed Student Health Coordination With CrossTx
School districts that help students receive mental health and healthcare treatment create safer, more inclusive learning environments. By making care...
UKs Largest Medical Cannabis Deal Signed by Releaf
Historic Multi-Million-Pound Deal is the UK's Largest Ever Medical Cannabis ContractThe UK's fastest-growing medical cannabis provider has signed a multi-million-pound...
Parexel Names Keri Mattox Chief Business Officer
Healthcare executive to lead company’s business operations and growth strategyDURHAM, N.C., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Parexel, one of...
QHSLab, Inc. Welcomes Dr. Juan D. Oms, MD, FAPA, as Medical Advisor for Psychiatry and Behavioral Health
WEST PALM BEACH, FL, Oct. 22, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital...
SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers
DENVER, Oct. 22, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary...
HealthLynked Announces Strategic Partnership with 3X4 Genetics to Enhance Member Offerings
NAPLES, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) -- -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a leading global healthcare network...
Celularity Provides Corporate Update
FLORHAM PARK, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, has...
Florida Oncology and Hematology and American Oncology Network Opens New Location in Cape Coral, Welcomes Medical Director, Dr. Van den Bergh, and Drs. Venkata Parsa, and Shivtaj Mann
Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO join the Cape Coral physician...
Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress
Data from an analysis of five NHP studies showed lumbar IT administration led to widespread and consistent biodistribution of AAV9...
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS.REC-3964 represents a novel, non-antibiotic approach with a unique mechanism...
Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury
Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from exposure...
Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment Combinations
Planned industry first clinical trial combining BeiGene's checkpoint inhibitor tislelizumab with Indaptus’ broadly targeted, short duration systemic immune stimulator Decoy20...
Viemed Healthcare Announces Third Quarter 2024 Earnings Conference Call Details
LAFAYETTE, La., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in...
ProPhase Labs to Present at the 2024 ThinkEquity Conference
GARDEN CITY, NY, Oct. 22, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next...
InnovAge to Announce Fiscal First Quarter 2025 Financial Results and Host Conference Call Tuesday, November 5, 2024
DENVER, Oct. 22, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in...
Lexeo Therapeutics to Present New Interim Data from Phase 1/2 Trial of LX1001 at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Conference
Late-breaking oral presentation to highlight safety and efficacy of LX1001 across four dose cohortsNEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE)...
Editas Medicine Announces Progress Towards 2024 Goals, Including Achievement of In Vivo Preclinical Proof of Concept and Strategic Update
Achieved in vivo preclinical proof of concept of hematopoietic stem and progenitor cell editing by utilizing Editas Medicine’s proprietary targeted...
Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis
MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of interleukin-1 blocker therapy (rilonacept or anakinra) and is expected...
111, Inc. to Participate in Fireside Chat with Water Tower Research on October 30, 2024
SHANGHAI, Oct. 22, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed...